J. Safra Asset Management’s Biogen BIIB Stock Holding History

J. Safra Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.5K	Sell	67 -15	-18%	-$2.87K	﹤0.01%	362
2026 Q1	$15K	Buy	82 +55	+204%	+$10.1K	﹤0.01%	336
2025 Q4	$4.75K	Buy	27 +12	+80%	+$1.96K	﹤0.01%	434
2025 Q3	$2.1K	Buy	+15	New	+$2.03K	﹤0.01%	397
2016 Q3	–	Sell	-79	Closed	-$19K	–	163
2016 Q2	$19K	Buy	+79	New	+$20.8K	0.03%	212

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

J. Safra Asset Management's BIIB Position: Q2 2026 in Review

J. Safra Asset Management reduced its Biogen (BIIB) stake by 18% in Q2 2026, selling an estimated $2.87K and leaving 67 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

J. Safra Asset Management first reported a position in BIIB in Q2 2016 and has held it in 5 quarters since. The position peaked at $19K in Q2 2016. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

J. Safra Asset Management held 67 shares of Biogen worth $14.5K as of Q2 2026.
J. Safra Asset Management sold 15 Biogen shares in Q2 2026, an estimated $2.87K.
Biogen made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #362 holding.
J. Safra Asset Management first reported a position in Biogen in Q2 2016 and has held it in 5 quarters since.
J. Safra Asset Management's Biogen position peaked at $19K in Q2 2016.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.